In this issue:
Should BRCA testing be expanded to relatives of men with hereditary prostate cancer?
Updates to NCCN Clinical Practice Guidelines
Prostate cancer treatment
Prostate cancer early detection
Detection, prevention, & risk reduction: Genetic/familial high-risk assessment
Guidelines for patients
TGA registration for enzalutamide expanded
New indication for darolutamide under evaluation
Updates to US approvals & designations
Recent amendments to the MBS
Extended Medicare Safety Net
POPSTAR II recruiting in Australia
Trial of darolutamide + opaganib for poor prognosis mCRPC commences
New Medicare handbook for health professionals
2025 ASCO Annual Meeting
ASCO Genitourinary Cancers Symposiums
COVID-19 resources
Conferences & Workshops
Please login below to download this issue (PDF)